Healthcare Sector

Hospital chains seek regulated reuse of single-use medical devices, warning that a blanket ban could raise procedure costs by 25-75% and disrupt dialysis services for nearly 500,000 patients.

India's pharmaceutical exports rose 4.9 per cent to $16.14 billion in H1FY27, driven by growth in Europe, ASEAN and Latin America, even as shipments to the US moderated.

India's pharma and healthcare sector recorded 87 deals worth $4.3 billion in Q3 2026, as private equity activity surged and public market fundraising gained momentum.

The drug regulator has asked states and UTs to enforce raw material testing and vendor qualification by manufacturers, following concerns over contaminated cough syrups and drug safety.

Experts warn that the 30% trade-margin cap on 137 anti-cancer drugs may offer limited relief to patients as assistance programmes remain excluded from price calculations.

The drugmaker's revenue rose 17.3 per cent to ₹4,338 crore in Q2 FY27, supported by strong demand for chronic therapies and growth in Bharat Serums and Vaccines' speciality portfolio.

The three-member committee will assess the effectiveness of the UCPMP, examine enforcement mechanisms and recommend measures to curb unethical pharmaceutical marketing practices

The managed care company plans to open five hospitals across Bengaluru over the next six months as its valuation triples from its previous fundraise, taking total funding past $120 million.

The NPPA's 30% trade margin cap on 137 oncology drugs, effective November 9, has drawn support from the pharma industry, while patient groups question its impact on affordability.

The ₹1,450-crore IPO comprises a ₹500-crore fresh issue and a ₹950-crore offer for sale, while the hospital chain plans to add 800 beds through projects in Gurugram and Ludhiana

Union Health Ministry seeks prominent display of healthcare service charges and package rates for foreign patients travelling to India on medical or Ayush visas to improve transparency.

Bench questions steep mark-ups on medicines and medical devices; Centre says price regulation must balance affordability with availability

The move could bring down the MRPs of cancer medicines by up to 70 per cent and save consumers an estimated ₹2,500 crore annually

Divi's Laboratories remains the top pick for most brokerages in this segment, even as valuations turn rich after the sharp rally

Bengaluru-based healthtech firm Tricog Health, which combines medical-grade AI, connected diagnostic technology, and specialist clinical expertise to deliver cardiac diagnosis, is targeting 100 million cardiac screenings by 2030. The company, founded in 2014, has screened over 41 million patients and currently screens over a million patients globally every month, Tricog Health Founder and CEO Dr Charit Bhograj told PTI in an interaction. Tricog Health, which began public health partnerships with the Goa government in 2018, has since expanded to Maharashtra, Telangana, Odisha, Bihar, Karnataka, and Manipur. It also operates in 14 Global South countries, including the Philippines, Malaysia, and Kenya. The expansion comes amid projections that cardiovascular disease will remain the single largest killer in India well beyond 2050, with one in five heart attacks occurring before age 45, Bhograj said. India has about 6,500 cardiologists and 50,000 physicians, as per estimates. According

Marengo Asia Hospitals and BAPIO Training Academy have partnered to launch two six-month certificate programmes to strengthen AYUSH doctors' clinical skills through structured teaching and supervised

Move could cut MRPs by up to 70%, save patients ₹2,500 crore annually; comes amid SC scrutiny of high mark-ups

Nearly $10 billion in global private equity has flowed into Indian hospital chains in five years, underscoring the growing role of private healthcare in meeting demand

The combined Maharashtra business is expected to generate around ₹500 crore in revenue this year, with plans to establish a presence in every district headquarters

Blackstone, KKR, TPG, General Atlantic and other global investors have spent about $10 billion buying stakes in Indian hospital chains over the past five years